ProNutri Dairy Foods — Financial Projections

The following financial projections are based on management estimates and have been prepared in accordance with the International Financial Reporting Standards (IFRS) as applicable to private companies in South Africa. All projections assume constant 2026 prices unless otherwise stated, with an annual…

ProNutri Dairy Foods (Pty) Ltd Business PlanSection 13 › Financial Projections

Section 13 · Business Plan

Financial Projections

The following financial projections are based on management estimates and have been prepared in accordance with the International Financial Reporting Standards (IFRS) as applicable to private companies in South Africa. All projections assume constant 2026 prices unless otherwise stated, with an annual…

Year 5 Revenue
R780,000,000

With a target EBITDA margin of around 22% and Year-5 net profit of R124.8 million, reaching profitability from Year 2.

The following financial projections are based on management estimates and have been prepared in accordance with the International Financial Reporting Standards (IFRS) as applicable to private companies in South Africa. All projections assume constant 2026 prices unless otherwise stated, with an annual inflation adjustment of 5% applied to revenues and operating costs.

13.1 Key Assumptions

Assumption Basis
Revenue growth Volume-driven ramp-up from 65% to 90% capacity utilisation, plus 5% annual price escalation
Raw milk cost R5.80/litre in Year 1, escalating at 5.5% per annum (in line with MPO cost trends)
Gross margin Improving from 28% to 39% as product mix shifts towards higher-margin value-added products
Staff costs Annual increases of 6.5% (CPI + 2%), reflecting collective bargaining norms
Corporate tax rate 27% (South Africa standard rate)
Depreciation Straight-line: buildings 20 years, equipment 10 years, vehicles 5 years
Working capital Debtors 45 days, creditors 30 days, inventory 21 days
Debt terms R90m senior debt at Prime + 1.5% (est. 12.75%), 7-year term, 18-month grace period
Discount rate (WACC) 16.5% (reflecting SA risk premium and capital structure)

13.2 Capital Expenditure Schedule

Category Amount (R'm) % of Total
Processing Equipment (imported) 58.0 32.2%
Building & Civil Works 42.0 23.3%
Cold Storage & Logistics Fleet 22.0 12.2%
Packaging Lines & Materials 18.0 10.0%
Working Capital (initial) 28.0 15.6%
Professional Fees & Contingency 12.0 6.7%
Total Capital Requirement 180.0 100.0%
Figure
Capex Breakdown — visualised from the accompanying data.

13.3 Projected Income Statement (Profit & Loss)

R'000 Year 1 Year 2 Year 3 Year 4 Year 5
Revenue 210,000 336,000 478,000 612,000 780,000
Cost of Sales (151,200) (226,800) (310,700) (382,500) (475,800)
Gross Profit 58,800 109,200 167,300 229,500 304,200
Gross Margin % 28.0% 32.5% 35.0% 37.5% 39.0%
Staff Costs (42,800) (55,800) (78,500) (95,200) (112,000)
Marketing & Distribution (10,500) (16,800) (23,900) (30,600) (39,000)
Utilities & Maintenance (8,400) (11,100) (14,300) (17,100) (20,300)
Administration & Other (6,300) (8,700) (11,500) (14,200) (17,400)
Total Operating Expenses (68,000) (92,400) (128,200) (157,100) (188,700)
EBITDA 25,200 53,800 93,200 128,500 175,500
EBITDA Margin % 12.0% 16.0% 19.5% 21.0% 22.5%
Depreciation & Amortisation (14,000) (14,500) (15,200) (15,800) (16,500)
EBIT 11,200 39,300 78,000 112,700 159,000
Interest Expense (11,475) (10,800) (9,800) (8,500) (7,000)
Profit Before Tax (275) 28,500 68,200 104,200 152,000
Taxation (27%) (3,300) (13,200) (18,500) (27,200)
Net Profit / (Loss) (5,275) 25,200 55,000 85,700 124,800
Net Profit Margin % (2.5%) 7.5% 11.5% 14.0% 16.0%

Note: Year 1 reflects a small net loss attributable to the ramp-up phase, interest costs on the senior debt facility during commissioning, and sub-optimal capacity utilisation. The Company benefits from accumulated tax losses carried forward into Year 2, resulting in a reduced effective tax rate in that period. From Year 3 onwards, the Company achieves strong profitability driven by improving capacity utilisation, an increasingly favourable product mix, and operating leverage.

Figure
Profitability Margins — visualised from the accompanying data.

13.4 Projected Balance Sheet

R'000 Year 1 Year 2 Year 3 Year 4 Year 5
ASSETS
Non-Current Assets
Property, Plant & Equipment 126,000 146,500 159,300 165,500 167,000
Intangible Assets 2,000 1,800 1,600 1,400 1,200
Total Non-Current Assets 128,000 148,300 160,900 166,900 168,200
Current Assets
Inventories 12,100 16,800 22,500 27,300 33,200
Trade Receivables 25,900 41,400 59,000 75,500 96,200
Cash & Cash Equivalents 8,500 13,500 52,900 124,000 232,200
Total Current Assets 46,500 71,700 134,400 226,800 361,600
TOTAL ASSETS 174,500 220,000 295,300 393,700 529,800
EQUITY AND LIABILITIES
Shareholders' Equity 84,725 109,925 164,925 250,625 375,425
Non-Current Liabilities
Long-Term Borrowings 72,000 64,000 56,000 44,000 30,000
Current Liabilities
Trade Payables 12,475 18,700 25,600 31,500 39,200
Short-Term Borrowings 8,000 12,000 12,000 12,000
Current Tax Payable 3,300 13,200 18,500 27,200
Accruals & Other 5,300 16,075 23,575 37,075 45,975
Total Current Liabilities 17,775 46,075 74,375 99,075 124,375
TOTAL EQUITY AND LIABILITIES 174,500 220,000 295,300 393,700 529,800

13.5 Projected Cash Flow Statement

R'000 Year 1 Year 2 Year 3 Year 4 Year 5
OPERATING ACTIVITIES
Net Profit / (Loss) (5,275) 25,200 55,000 85,700 124,800
Add: Depreciation & Amortisation 14,000 14,500 15,200 15,800 16,500
Add: Interest Expense 11,475 10,800 9,800 8,500 7,000
Working Capital Changes (1,700) (2,300) (2,500) (2,200) (2,100)
Tax Paid (3,300) (13,200) (18,500)
Interest Paid (11,475) (10,800) (9,800) (8,500) (7,000)
Net Cash from Operations 18,500 48,200 82,500 115,800 158,200
INVESTING ACTIVITIES
Purchase of PPE (95,000) (35,000) (28,000) (22,000) (18,000)
Net Cash from Investing (95,000) (35,000) (28,000) (22,000) (18,000)
FINANCING ACTIVITIES
Equity Raised 90,000
Debt Drawdown 90,000
Debt Repayment (8,000) (15,000) (22,000) (30,000)
Dividends Paid (2,000)
Working Capital Facility (5,000) (700) (500)
Net Cash from Financing 85,000 (8,000) (15,000) (22,700) (32,500)
Net Change in Cash 8,500 5,200 39,500 71,100 107,700
Opening Cash Balance 8,500 13,500 52,900 124,000
Closing Cash Balance 8,500 13,500 52,900 124,000 232,200
Figure
Cashflow Summary — visualised from the accompanying data.

13.6 Key Financial Ratios and Investor Metrics

Ratio / Metric Year 1 Year 2 Year 3 Year 4 Year 5
PROFITABILITY
Gross Margin 28.0% 32.5% 35.0% 37.5% 39.0%
EBITDA Margin 12.0% 16.0% 19.5% 21.0% 22.5%
Net Profit Margin (2.5%) 7.5% 11.5% 14.0% 16.0%
Return on Equity (ROE) (6.2%) 22.9% 33.3% 34.2% 33.3%
Return on Assets (ROA) (3.0%) 11.5% 18.6% 21.8% 23.6%
LIQUIDITY
Current Ratio 2.62x 1.56x 1.81x 2.29x 2.91x
Quick Ratio 1.94x 1.19x 1.50x 2.01x 2.64x
LEVERAGE
Debt-to-Equity 0.85x 0.65x 0.41x 0.22x 0.11x
Net Debt / EBITDA 2.52x 1.09x 0.03x Net Cash Net Cash
Interest Cover (EBIT/Interest) 0.98x 3.64x 7.96x 13.26x 22.71x
DSCR (Cash flow basis) 0.80x 1.60x 2.40x 3.10x 3.80x
VALUATION
EV/EBITDA 5.2x
Project IRR (7-year) 24.8%
Equity IRR (7-year) 31.5%
Payback Period 4.2 years
Figure
Dscr Roe — visualised from the accompanying data.

13.7 Break-Even Analysis

The break-even analysis determines the minimum annual production volume at which total revenues equal total costs (fixed plus variable). Based on an average selling price of R4.20 per litre equivalent and variable costs of R2.80 per litre, the Company’s annual fixed cost base of approximately R65 million results in a break-even volume of approximately 46.4 million litres per annum. This equates to a daily processing volume of approximately 141,000 litres, representing approximately 47% of the Year 5 capacity target. The Company is projected to achieve break-even on a monthly cash flow basis by Month 14 of commercial operations.

Figure
Breakeven — visualised from the accompanying data.

13.8 Sensitivity Analysis

Scenario Impact on Y5 EBITDA Impact on IRR
Base Case R175.5m 24.8%
Raw milk cost +10% R128.2m (-27%) 18.5%
Raw milk cost -10% R222.8m (+27%) 30.2%
Revenue volume -15% R118.8m (-32%) 16.2%
Revenue volume +15% R232.2m (+32%) 32.5%
6-month commissioning delay R175.5m (Y5 unchanged) 21.3%
Interest rate +200bps R175.5m (no EBITDA impact) 23.1%
ZAR depreciation 10% (import costs) R169.3m (-4%) 23.8%

The sensitivity analysis demonstrates that the project is most sensitive to raw milk input costs and revenue volume. Management will mitigate raw milk price risk through long-term supply contracts with price escalation mechanisms, and volume risk through diversified customer channels and aggressive market development. The project remains economically viable (IRR exceeds WACC of 16.5%) under all individual stress scenarios tested.

This document contains proprietary and confidential information. Distribution without written consent is prohibited.